MLEC: A Potential Drug Target and Biomarker (G9761)
MLEC: A Potential Drug Target and Biomarker
MLEC (MLEC-HUMAN) is a protein that is expressed in various tissues of the human body, including the nervous system, endothelial cells, and epithelial cells. It is a member of the MLEC (Mucin-Like Extracellular Matrix) family, which is Characterized by the presence of a secreted portion of the cell that is similar to mucin, a protein produced by glands and other epithelial cells.
MLEC has been shown to play a role in various physiological processes in the body, including cell signaling, migration, and invasion. It is also involved in the development and maintenance of tissues, including the placenta and the uropeptide transdermal absorption system.
MLEC has also been identified as a potential drug target, due to its involvement in various diseases and its ability to interact with certain signaling pathways. For example, MLEC has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It is also thought to play a role in cancer, with studies showing that MLEC is often overexpressed in cancer cells.
In addition to its potential as a drug target, MLEC is also of interest as a biomarker for certain diseases. For example, MLEC has been shown to be elevated in the brains of individuals with Alzheimer's disease, and may be a useful diagnostic marker for this disease. Additionally, MLEC has been shown to be decreased in the blood of individuals with certain types of cancer, which may make it a useful indicator for the disease.
Overall, MLEC is a protein that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in various biological processes and its potential as a therapeutic agent.
Protein Name: Malectin
Functions: Carbohydrate-binding protein with a strong ligand preference for Glc2-N-glycan. May play a role in the early steps of protein N-glycosylation (By similarity)
The "MLEC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MLEC comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MLF1 | MLF1-DT | MLF2 | MLH1 | MLH3 | MLIP | MLIP-AS1 | MLKL | MLLT1 | MLLT10 | MLLT10P1 | MLLT11 | MLLT3 | MLLT6 | MLN | MLNR | MLPH | MLST8 | MLX | MLXIP | MLXIPL | MLYCD | MMAA | MMAB | MMACHC | MMADHC | MMADHC-DT | MMD | MMD2 | MME | MMEL1 | MMGT1 | MMP | MMP1 | MMP10 | MMP11 | MMP12 | MMP13 | MMP14 | MMP15 | MMP16 | MMP17 | MMP19 | MMP2 | MMP2-AS1 | MMP20 | MMP20-AS1 | MMP21 | MMP23A | MMP23B | MMP24 | MMP24-AS1-EDEM2 | MMP24OS | MMP25 | MMP25-AS1 | MMP26 | MMP27 | MMP28 | MMP3 | MMP7 | MMP8 | MMP9 | MMRN1 | MMRN2 | MMS19 | MMS22L | MMS22L-TONSL complex | MMUT | MMXD complex | MN1 | MNAT1 | MND1 | MNDA | MNS1 | MNT | MNX1 | MNX1-AS1 | MOAP1 | MOB1A | MOB1B | MOB2 | MOB3A | MOB3B | MOB3C | MOB4 | MOBP | MOCOS | MOCS1 | MOCS2 | MOCS2-DT | MOCS3 | MOG | MOGAT1 | MOGAT2 | MOGAT3 | MOGS | MOK | MON1A | MON1B | MON2
